|
|
|
|
U of Maryland receives $20 million to create national genome sequencing hub
BALTIMORE, Md.-The 's has been awarded $20 million from the to create a Genomic Sequencing Center for Infectious Diseases.The contract, the largest the Institute for Genome Sciences has earned since its founding two years ago, makes IGS a...
|
|
|
Emergent BioSolutions Receives FDA Approval Extending Shelf Life of BioThrax Anthrax Vaccine Adsorbed to 4 Yea
- (NewsRx.com) -- Emergent BioSolutions Inc.(NYSE:EBS) announced that its flagship product, BioThrax (Anthrax Vaccine Adsorbed), has been granted a shelf life extension from 3 to 4 years by the U.S. Food and Drug Administration (FDA).
|
|
|
Pharmacological Exploitation of an Off-Target Antibacterial Effect of the Cyclooxygenase-2 Inhibitor Celecoxib
Francisella tularensis, a bacterium which causes tularemia in humans, is classified as a CDC category A bioterrorism agent.In this study, we demonstrate that celecoxib, an anti-inflammatory cyclooxygenase-2 inhibitor in clinical use...
|
|
|
Scientists Block Ebola Infection In Cell-Culture Experiments
Researchers at the University of Texas Medical Branch at Galveston have discovered two biochemical pathways that the Ebola virus relies on to infect cells.Using substances that block the activation of those pathways, they've prevented...
|
|
|
National Jewish Health and Ceragenix Announce Compound Shows Promise for Treating Potentially Lethal Viral Inf
Vaccinia virus infections are of concern as the current smallpox vaccine uses this live virus to inoculate persons against a potential bioterror smallpox attack.Use of the vaccine is contraindicated in persons who are...
|
|
|
$37 million to extend regional biodefense and emerging infectious diseases research
-- The National Institutes of Health (NIH) has extended funding for the Midwest Regional Center for Excellence in Biodefense and Emerging Infectious Diseases (MRCE), anchored at Washington University in St.Louis. The center received a...
|
|
|
National Jewish Health And Ceragenix Announce Compound Shows Promise For Treating Potentially Lethal Viral Inf
Ceragenix Pharmaceuticals, Inc.('Ceragenix') (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, announced that researchers at National Jewish Health, led by Dr.Donald Y. Leung and Dr. Michael Howell,...
|
|
|
Scientists Block Ebola Infection in Cell-Culture Experiments
Researchers at the University of Texas Medical Branch at Galveston have discovered two biochemical pathways that the Ebola virus relies on to infect cells.Using substances that block the activation of those pathways, they've prevented...
|
|
|
Scientists block Ebola infection in cell-culture experiments
Researchers at the University of Texas Medical Branch at Galveston have discovered two biochemical pathways that the Ebola virus relies on to infect cells.Using substances that block the activation of those pathways, they've prevented...
|
|
|
Scientists block Ebola infection in cell-culture experiments
GALVESTON, Texas Researchers at the University of Texas Medical Branch at Galveston have discovered two biochemical pathways that the Ebola virus relies on to infect cells.Using substances that block the activation of those pathways, they...
|
|
|
Scientists block Ebola infection in cell-culture experiments - could lead to first therapy
Researchers at the University of Texas Medical Branch at Galveston have discovered two biochemical pathways that the Ebola virus relies on to infect cells.Using substances that block the activation of those pathways, they've prevented...
|
|
|
Scientists block Ebola infection in cell-culture experiments
GALVESTON, Texas Researchers at the have discovered two biochemical pathways that the Ebola virus relies on to infect cells.Using substances that block the activation of those pathways, they've prevented Ebola infection in cell culture...
|
|
|
HHS Secretary Congratulates New FDA Commissioner
Save in My Library Free Full Text Health and Human Services Secretary Kathleen Sebelius officially congratulated new FDA Commissioner Dr.Margaret 'Peggy' Hamburg, who was unanimously confirmed by the Senate recently. Hamburg is a...
|
|
|
National Jewish Health and Ceragenix Announce Compound Shows Promise for Treating Potentially Lethal Viral Inf
- Ceragenix Pharmaceuticals, Inc.(Ceragenix) (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that researchers at National Jewish Health, led by Dr.Donald Y. Leung and Dr. Michael...
|
|
|
National Jewish Health and Ceragenix Announce Compound Shows Promise for Treating Potentially Lethal Viral Inf
DENVER - (BUSINESS WIRE) - Ceragenix Pharmaceuticals, Inc.('Ceragenix' ) (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that researchers at National Jewish Health, led by Dr.Donald Y....
|
|
|
National Jewish Health and Ceragenix Announce Compound Shows Promise for Treating Potentially Lethal Viral Inf
Ceragenix Pharmaceuticals, Inc.(Ceragenix) (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that researchers at National Jewish Health, led by Dr.Donald Y. Leung and Dr. Michael...
|
|
|
New discovery on how botulism paralyzes nerve cells
New structures of a botulism toxin interacting with a mimic of the nerve-cell protein it destroys suggest new ways to block this often-fatal interaction.Indeed, the mimic molecules have such high affinity for the toxin and bind to it so...
|
|
|
Best Practices: Big Plans
In April, the world was enthralled by news of influenza H1N1, the new swine flu strain that quickly spread through Mexico and the world.With this latest threat of a pandemic, hospital leaders no doubt asked the question that has haunted...
|
|
|
Universal Detection Technology Applies for CAGE and NSN Codes for Its Biological Detection Equipment
Universal Detection Technology (www.udetection.com) (OTCBB: UNDT), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism...
|
|
|
Pharmaceutical Excipients for Oral Formulations, 2nd. Edition - New Market Analysis
www.companiesandmarkets.com/Summary-Market-Report/pharmaceutical ..Pharmaceutical Excipients, especially those for solid oral dosage forms, have very much been taken for granted and, until recently, have been largely ignored by chemical...
|
|
|
Universal Detection Technology Applies For CAGE And NSN Codes For Its Biological Detection Equipment
Universal Detection Technology (OTCBB: UNDT), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training...
|
|
|
Universal Detection Technology Applies for CAGE and NSN Codes for Its Biological Detection Equipment
Universal Detection Technology (www.udetection.com) (OTCBB: UNDT), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism...
|
|
|
Emergent BioSolutions Receives FDA Approval Extending Shelf Life Of BioThrax (Anthrax Vaccine Adsorbed) To 4 Y
Emergent BioSolutions Inc.(NYSE:EBS) announced that its flagship product, BioThrax (Anthrax Vaccine Adsorbed), has been granted a shelf life extension from 3 to 4 years by the U.S. Food and Drug Administration (FDA). Based on this...
|
|
|
Emergent BioSolutions Receives FDA Approval Extending Shelf Life of BioThrax (Anthrax Vaccine Adsorbed) to 4 Y
ROCKVILLE, Md.--(BUSINESS WIRE)-- Emergent BioSolutions Inc.(NYSE:EBS) announced today that its flagship product, BioThrax (Anthrax Vaccine Adsorbed), has been granted a shelf life extension from 3 to 4 years by the U.S. Food and Drug...
|
|
|
Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis-C Virus (HCV)
LOGO-b) To our Shareholders: On March 25th we announced a data driven strategy to improve Hepatitis-C virus (HCV) cure rates by combining the benefit of our Hemopurifier(R) with the interferon-ribavirin standard of care (SOC) administered to...
|
